Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation

NCT01894035 · clinicaltrials.gov ↗

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension

Interventions

DRUG: Iloprost (Ventavis, BAYQ 6256)

Sponsor

Bayer